Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tufts Report Finds No Benefit From Routine Pulmonary Artery Catheterization

This article was originally published in The Gray Sheet

Executive Summary

Pulmonary artery catheterization for monitoring cardiac function was once common in the intensive care units, but a new technology assessment requested by the government shows there is little evidence that the procedure is effective in critical care settings

You may also be interested in...



Pulmonary Artery Catheter Use Down Sharply, Research Shows

Pulmonary artery catheterization in the United States - once common for critical care - has dropped so dramatically that it should either be discontinued entirely or performed only by physicians highly skilled in the procedure, according to articles in the July 25 Journal of the American Medical Association.

Keeping Track: US FDA's Rejection Of First RMAT BLA Blemishes Otherwise Positive Week Of Non-Oncology News

The latest non-oncology drug development news and highlights from our US FDA Performance Tracker.

FDA Commissioner Nominee Hahn Advances To Full Senate, Despite Some Dems’ Reservations

Stephen Hahn, the Trump administration’s nominee to lead the US FDA, has been approved by the Senate Health, Education, Labor and Pensions (HELP) Committee, with some “no votes” from Democratic senators in leadership positions, and is expected to be considered by the full Senate this week.

UsernamePublicRestriction

Register

MT026680

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel